Previous research has underscored the pivotal role of CCL5, produced by both cNK cells and ILC1s, in facilitating the accumulation of DCs within the tumor microenvironment, thereby impeding tumor immune evasion, as highlighted in studies (Böttcher et al., 2018; Kirchhammer et al., 2022). Here, CCL5 is linked to neoplasm.